Saluda Medical shares plummet on Australian market debut – Reuters

1. Saluda Medical shares plummet on Australian market debut  Reuters
2. Biocurious: Saluda Medical’s IPO tackles the $35-billion-a-year chronic pain market  Stockhead
3. Saluda Medical the latest Aussie-founded medtech set for an ASX debut after raising…

Continue Reading